Le Lézard
Classified in: Business
Subjects: OTC, ATY

PixarBio Corporation Investigated For Securities Fraud By Block & Leviton Following Suspension In Trading By SEC


BOSTON, Jan. 25, 2017 /PRNewswire/ -- Block & Leviton LLP (www.blockesq.com), a Boston based securities litigation firm representing investors nationwide, is investigating whether PixarBio Corporation ("PixarBio" or the "Company") (OTMTK: PXRB) and certain of its officers and directors violated federal securities laws following the news that the SEC has halted trading of the company's shares, citing possible "manipulative or deceptive activities."

On January 3, 2017, PixarBio's CEO announced a purported attempt by the Company to acquire InVivo Therapeutics Holdings Corp. ("InVivo") in a $100 million takeover bid. InVivo refuted PixarBio's purported offer as "not credible."

On January 23, 2017, the U.S. Securities and Exchange Commission halted trading in the securities of PixarBio, citing concerns about possible "manipulative or deceptive activities" in the market for the Company's stock. The SEC stated, in part, that "because the market for the security appears to reflect manipulative or deceptive activities and because of questions regarding the accuracy of assertions by PixarBio in press releases and its Form S-1 concerning, among other things: (1) the company's business combinations and current shareholders; (2) the identity and qualifications of key shareholders and employees; and (3) the company's current and prospective development efforts."

PixarBio stock has fallen more than 30% since January 3, causing tens of millions in losses to investors.

If you recently purchased or otherwise acquired PixarBio securities and have questions about your legal rights or possess information relevant to this investigation, please contact attorney Bradley Vettraino at (617) 398-5600, by email at [email protected], or by visiting www.blockesq.com/pixarbio. Confidentiality to whistleblowers or others with information relevant to the lawsuit is assured.

Block & Leviton LLP is a Boston-based law firm representing investors nationwide. The firm's lawyers have collectively been prosecuting securities cases on behalf of individual and institutional investors for over 50 years, and have recovered billions of dollars on their behalf. Block & Leviton's investigations into corporate wrongdoing were recently covered by the New York Times.

This notice may constitute attorney advertising.

CONTACT:

Block & Leviton LLP
Bradley J. Vettraino
155 Federal Street, Suite 400
Boston, MA 02110
(617) 398-5600
[email protected]

SOURCE Block & Leviton LLP


These press releases may also interest you

at 09:48
On 24 April 2024, K1 Investment...

at 09:45
Odyssey Marine Exploration, Inc. , a global subsea mineral exploration and validation company, filed a Comprehensive Form 10-K for the year ended December 31, 2023, which included restated financial statements for the year ended December 31, 2022,...

at 09:45
Americans continue to signal that travel is splurge-worthy and are again setting new records for vacation spending in 2024. For a second consecutive year, Allianz Partners USA's annual Vacation Confidence Index* found that Americans' total spend on...

at 09:44
Rick's journey in the mortgage industry began as a loan officer, driven by his passion for assisting individuals and families in achieving their dreams of homeownership. He has since built an impressive career, including founding and leading multiple...

at 09:38
Kinderhook Industries, LLC ("Kinderhook") announced today an investment in Apex Waste Solutions ("Apex") in partnership with management. Apex is a leading regional solid waste collection company serving more than 75,000 customers across the Colorado...

at 09:35
Pager, Inc., a leading digital healthcare enablement and care advocacy company serving 28 million members in the United States and Latin America, and AXA Partners Mexico (APM) today announced a strategic partnership that provides new capabilities to...



News published on and distributed by: